Literature DB >> 23766520

Increased parameters of oxidative stress and its relation to transfusion iron overload in patients with myelodysplastic syndromes.

Geane Felix de Souza1, Maritza Cavalcante Barbosa, Talyta Ellen de Jesus Santos, Teresa Maria de Jesus Ponte Carvalho, Rivelilson Mendes de Freitas, Manoel Ricardo Alves Martins, Romélia Pinheiro Gonçalves, Ronald Feitosa Pinheiro, Silvia Maria Meira Magalhães.   

Abstract

Entities:  

Keywords:  Free Radical; Iron; Myelodysplasia

Mesh：

Substances：

Year:  2013        PMID： 23766520     DOI： 10.1136/jclinpath-2012-201288

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  8 in total

Review 1.  Iron overload in myelodysplastic syndromes (MDS).

Authors:  Norbert Gattermann
Journal:  Int J Hematol       Date:  2017-11-25       Impact factor: 2.490

2.  HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross-sectional study.

Authors:  Geane Felix De Souza; Howard Lopes Ribeiro; Juliana Cordeiro De Sousa; Fabíola Fernandes Heredia; Rivelilson Mendes De Freitas; Manoel Ricardo Alves Martins; Romélia Pinheiro Gonçalves; Ronald Feitosa Pinheiro; Silvia Maria Meira Magalhães
Journal:  BMJ Open       Date:  2015-04-03       Impact factor: 2.692

Review 3.  Lipid Peroxidation-Derived Aldehydes, 4-Hydroxynonenal and Malondialdehyde in Aging-Related Disorders.

Authors:  Giuseppina Barrera; Stefania Pizzimenti; Martina Daga; Chiara Dianzani; Alessia Arcaro; Giovanni Paolo Cetrangolo; Giulio Giordano; Marie Angele Cucci; Maria Graf; Fabrizio Gentile
Journal:  Antioxidants (Basel)       Date:  2018-07-30

4.  Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry.

Authors:  Marlijn Hoeks; Ge Yu; Saskia Langemeijer; Simon Crouch; Louise de Swart; Pierre Fenaux; Argiris Symeonidis; Jaroslav Čermák; Eva Hellström-Lindberg; Guillermo Sanz; Reinhard Stauder; Mette Skov Holm; Moshe Mittelman; Krzysztof Mądry; Luca Malcovati; Aurelia Tatic; Antonio Medina Almeida; Ulrich Germing; Aleksandar Savic; Njetočka Gredelj Šimec; Dominic Culligan; Raphael Itzykson; Agnes Guerci-Bresler; Borhane Slama; Jackie Droste; Corine van Marrewijk; Arjan van de Loosdrecht; Nicole Blijlevens; Marian van Kraaij; David Bowen; Theo de Witte; Alex Smith
Journal:  Haematologica       Date:  2019-07-05       Impact factor: 9.941

Review 5.  The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia.

Authors:  Sarah Weber; Anastasia Parmon; Nina Kurrle; Frank Schnütgen; Hubert Serve
Journal:  Front Immunol       Date:  2021-02-19       Impact factor: 7.561

Review 6.  EnvIRONmental Aspects in Myelodysplastic Syndrome.

Authors:  Verena Petzer; Igor Theurl; Günter Weiss; Dominik Wolf
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

7.  Variability of the transferrin receptor 2 gene in AMD.

Authors:  Daniel Wysokinski; Janusz Blasiak; Mariola Dorecka; Marta Kowalska; Jacek Robaszkiewicz; Elzbieta Pawlowska; Jerzy Szaflik; Jacek Pawel Szaflik
Journal:  Dis Markers       Date:  2014-02-06       Impact factor: 3.434

8.  Effect of 5-Azacitidine Treatment on Redox Status and Inflammatory Condition in MDS Patients.

Authors:  Paola Montes; Ana Guerra-Librero; Paloma García; María Elena Cornejo-Calvo; María Del Señor López; Tomás de Haro; Laura Martínez-Ruiz; Germaine Escames; Darío Acuña-Castroviejo
Journal:  Antioxidants (Basel)       Date:  2022-01-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.